PRTN3 and rheumatoid arthritis: Rheumatoid arthritis (RA), for example, has shared epitope positive, rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA) positive cases that respond to B- or T-cell targeting with agents such as Rituximab or Abatacept which are very much in the autoimmune spectrum (15, 16).